Download PDF
Erfahrungsheilkunde 2015; 64(1): 14-20
DOI: 10.1055/s-0034-1395831
Wissen
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Curcumin bei entzündlichen ­Erkrankungen

Birgit Goyvaerts
,
Stefan Bruhn
,
Günter Seelinger
Further Information

Publication History

Publication Date:
27 February 2015 (online)

    Permissions and Reprints

Zusammenfassung

Antiinflammatorische und antioxidative Wirkungen von Curcumin, dem Hauptwirkstoff der Gelbwurz (Curcuma longa L.) sind in zahlreichen Studien gut belegt. Die klinische Wirksamkeit wird erst in den letzten Jahren intensiver erforscht. Aufgrund der schlechten Bioverfügbarkeit wurden die Studien teilweise mit sehr hohen oralen Dosen bis 12 g pro Tag durchgeführt. Eine Erleichterung stellen resorptionsfördernde galenische Zubereitungen dar. Erst kürzlich wurde über eine vielversprechende Formulierung mit in Mizellen eingeschlossenem gelöstem Curcumin berichtet.

Abstract

Numerous pharmacological studies have demonstrated manifold anti-inflammatory and anti-oxidative activities of curcumin, the main active component in turmeric (Curcuma longa L.). Clinical efficacy however has been investigated more intensively in the most recent years. Bioavailability of curcumin is poor, and some investigations used high amounts of up to 12 g per day. Formulations improving bioavailability may solve this problem. A new formulation with curcumin in liquid micelles is promising.

Schlüsselwörter

Curcuma - Curcumin - Bioverfügbarkeit - Entzündung - klinische Wirksamkeit

Keywords

Curcuma - Curcumin - Bioavailability - Inflammation - clinical Efficacy
 

  • Literatur

  • 1 Appendino G, Belcaro G, Cornelli U et al. Potential role of curcuminphytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Med 2011; 53 (3 Suppl 1): 43-49
    PubMedGoogle Scholar
  • 2 Barve A, Khor TO, Hao X et al. Murine prostate cancer inhibition by dietary phytochemicals--curcumin and phenyethylisothiocyanate. Pharm Res 2008; 25: 2181-2189
    CrossrefPubMedGoogle Scholar
  • 3 Baum L, Lam CW, Cheung SK et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 2008; 28: 110-113
    CrossrefPubMedGoogle Scholar
  • 4 Belcaro G, Cesarone MR, Dugall M et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev 2010; 15: 337-344
    PubMedGoogle Scholar
  • 5 Belcaro G, Hosoi M, Pellegrini L et al. A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment. Phytother Res 2014; 28: 444-450
    CrossrefPubMedGoogle Scholar
  • 6 Chainani-Wu N, Silverman SJr, Reingold A et al. A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus. Phytomedicine 2007; 14: 437-446
    CrossrefPubMedGoogle Scholar
  • 7 Chainani-Wu N, Madden E, Lozada-Nur F et al. High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. J Am Acad Dermatol 2012; 66: 752-760
    CrossrefPubMedGoogle Scholar
  • 8 Chainani-Wu N, Collins K, Silverman SJr. Use of curcuminoids in a cohort of patients with oral lichen planus, an autoimmune disease. Phytomedicine 2012; 19: 418-423
    CrossrefPubMedGoogle Scholar
  • 9 Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 2012; 26: 1719-1725
    CrossrefPubMedGoogle Scholar
  • 10 Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R et al. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012; 35: 2121-2127
    CrossrefPubMedGoogle Scholar
  • 11 Chuengsamarn S, Rattanamongkolgul S, Phonrat B et al. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem 2014; 25: 144-150
    CrossrefPubMedGoogle Scholar
  • 12 Cramer H, Lauche R, Klose P et al. Komplementäre, alternative und integrative Therapien in den medizinischen Leitlinien − die Leitlinie «Diagnostik und Therapie der Colitis ulcerosa» als Beispiel gelungener Integration. Forsch Komplementmed 2014; 21: 4-6
    PubMedGoogle Scholar
  • 13 Dignass A, Preiss JC, Aust DE et al. Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 − Ergebnisse einer evidenzbasierten Konsensuskonferenz. Z Gastroenterol 2011; 49: 1276-1341
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 DiSilvestro RA, Joseph E, Zhao S et al. Diverse effects of a low dose supplement of lapidated curcumin in healthy middle aged people. Nutrition Journal 2012; 11: 7986-
    PubMedGoogle Scholar
  • 15 EMA (HMPC) Community herbal monograph on Curcuma longa L., rhizome. EMA/HMPC/456845/2008. London, 12 November 2009
    PubMedGoogle Scholar
  • 16 Esatbeyoglu T, Huebbe P, Ernst IM et al. Curcumin − from molecule to biological function. AngewChem, Int Ed Engl 2012; 51(22): 5308-5332
    PubMedGoogle Scholar
  • 17 Frautschy SA, Hu W, Kim P et al. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 2001; 22: 9931005-
    PubMedGoogle Scholar
  • 18 Gelbe Liste Pharmindex. http://www.gelbe-liste.de. Letzter Zugriff 29.10.2014
    PubMedGoogle Scholar
  • 19 Hagl S, Heinrich M, Kocher A et al. Curcumin micelles improve mitochondrial function in a mouse model of Alzheimer’s disease. JPAD 2014; 2: 8083-
    PubMedGoogle Scholar
  • 20 Hanai H, Iida T, Takeuchi K et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006; 4: 1502-1506
    CrossrefPubMedGoogle Scholar
  • 21 Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 2005; 50: 2191-2193
    CrossrefPubMedGoogle Scholar
  • 22 Irving GR, Howells LM, Sale S et al. Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability. Cancer Prev Res (Phila) 2013; 6: 119-128
    CrossrefPubMedGoogle Scholar
  • 23 Kanai M, Otsuka Y, Otsuka K et al. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother Pharmacol 2013; 71: 1521-1530
    CrossrefPubMedGoogle Scholar
  • 24 Khor TO, Huang Y, Wu TY et al. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGsdemethylation. Biochem Pharmacol 2011; 82: 1073-1078
    CrossrefPubMedGoogle Scholar
  • 25 Kommission E. Monographie Curcumaelongaerhizoma (Curcumawurzelstock). Bundesanzeiger Nr. 223 vom 30.11.1985
    PubMedGoogle Scholar
  • 26 Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with kneeosteoarthritis: a multicenterstudy. Clinical Interventions in Aging 2014; 9: 451458-
    PubMedGoogle Scholar
  • 27 Lim GP, Chu T, Yang F et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001; 21: 8370-8377
    Google Scholar
  • 28 Na LX, Li Y, Pan HZ, Zhou XL et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res 2013; 57: 1569-1577
    CrossrefPubMedGoogle Scholar
  • 29 Ng TP, Chiam PC, Lee T et al. Curry consumption and cognitive function in the elderly. Am J Epidemiol 2006; 164: 898906-
    PubMedGoogle Scholar
  • 30 Owaga EE, Mpondab J Nyang'injac RA Nutrigenomic approach in understanding the antiallergic effects of curcumin. Asian J Biomed Pharmaceut Sci 2014; 4: 1-5
    PubMedGoogle Scholar
  • 31 Pinsornsak P, Niempoog S. The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thai 2012; 95 Suppl 1 S 51-58
    PubMedGoogle Scholar
  • 32 Ryan JL, Heckler CE, Ling M et al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 2013; 180: 3443-
    PubMedGoogle Scholar
  • 33 Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 2014; 28: 633-642
    CrossrefPubMedGoogle Scholar
  • 34 Schiborr C, Kocher A, Behnam D et al. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res 2014; 58: 516-527
    CrossrefPubMedGoogle Scholar
  • 35 Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors 2013; 39: 6977-
    PubMedGoogle Scholar
  • 36 Steigerwalt R, Nebbioso M, Appendino G et al. Meriva®, a lecithinizedcurcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med 2012; 54 (1 Suppl 4): 11-16
    PubMedGoogle Scholar
  • 37 Suskind DL, Wahbeh G, Burpee T et al. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. J Pediatr Gastroenterol Nutr 2013; 56: 277-279
    CrossrefPubMedGoogle Scholar
  • 38 Usharani P, Mateen AA, Naidu MU et al. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D 2008; 9: 243-250
    CrossrefPubMedGoogle Scholar
  • 39 WHO: Dementia − a public health priority. WHO Press 2012
    PubMedGoogle Scholar
  • 40 Zhang DW, Fu M, Gao SH et al. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med 2013; 2013: 636-653
    PubMedGoogle Scholar